MARKET

PLX

PLX

Protalix Biother
AMEX
1.110
0.000
0.00%
Opening 15:56 11/29 EST
OPEN
1.120
PREV CLOSE
1.110
HIGH
1.135
LOW
1.110
VOLUME
96.79K
TURNOVER
78.54K
52 WEEK HIGH
2.000
52 WEEK LOW
0.7000
MARKET CAP
56.24M
P/E (TTM)
-2.9065
1D
5D
1M
3M
1Y
5Y
PLX: BLA Submitted: 1H:23 Responses
By John Vandermosten, CFA NYSE:PLX READ THE FULL PLX RESEARCH REPORT Third Quarter Financial and Operational Review Protalix Biotherapeutics, Inc. (NYSE:PLX) announced its 3Q:22 financial and operational results in a November 14, 2022 press release and fil...
Zacks Small Cap Research · 11/15 09:46
TLRY, SI and MNDY are among pre market gainers
Seekingalpha · 11/14 13:54
5 stocks to watch on Monday: Hasbro, AMD and more
Seekingalpha · 11/14 13:33
BRIEF-Protalix Biotherapeutics And Chiesi Global Rare Diseases To Resubmit BLA For Pegunigalsidase Alfa
Reuters · 11/14 13:01
Protalix stock rises on on FDA refiling for Fabry disease drug PRX–102
Seekingalpha · 11/14 12:57
Protalix BioTherapeutics GAAP EPS of -$0.07, revenue of $14.18M
Seekingalpha · 11/14 11:54
Protalix BioTherapeutics Q3 EPS $(0.07) Up From $(0.09) YoY, Sales $14.18M Up From $12.05M YoY
Benzinga · 11/14 11:52
BRIEF-Protalix Biotherapeutics Reports Q3 2022 Financial Results
Reuters · 11/14 11:52
More
About PLX
Protalix Biotherapeutics Inc is an Israel-based biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cell-based protein expression system. Its system represents a new method for developing recombinant proteins in an industrial-scale manner. Company's aim is to develop tailored complex recombinant therapeutic proteins primarily produced through ProCellEx (platform). Through its platform Protalix Biotherapeutics Inc develops Elelyso, for the treatment of Gaucher disease as well as a pipeline of products such as, pegunigalsidase alfa, or PRX-102, for the potential treatment of Fabry disease is in advanced clinical stages.

Webull offers kinds of Protalix Biotherapeutics Inc stock information, including AMEX:PLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PLX stock methods without spending real money on the virtual paper trading platform.